Skip to main content
    N

    NanoViricides Inc (NNVC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.24
    +0.00 (+0.41%)

    Market Cap: $31.41M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    NanoViricides Inc (NNVC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect NanoViricides (NNVC) to earn -$0.35 per share in the fiscal year ending Jun 30, 2027. Over the last 30 days, 1 estimate for the fiscal year ending Jun 30, 2027 was revised up and 0 down. For the fiscal year ending Jun 30, 2028, the EPS consensus is -$0.35.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus is unchanged.

    Fiscal year ending Jun 30, 2027
    -$0.35
    EPS consensus
    Fiscal year ending Jun 30, 2028
    -$0.35
    EPS consensus, revenue $76.50M

    EPS range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Jun 30, 2027-$0.35-$0.35 to -$0.351N/AN/A1
    Jun 30, 2028-$0.35-$0.35 to -$0.351$76.50M$76.50M to $76.50M1

    Quarterly Estimates

    Quarter endingEPS consensusEPS rangeEPS analysts
    Dec 31, 2026-$0.08-$0.08 to -$0.081

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 1 upward and 0 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Jun 30, 202710
    Fiscal year ending Jun 30, 202800
    Quarter ending Dec 31, 202600

    EPS Trend

    The EPS consensus for the fiscal year ending Jun 30, 2027 has held over the last 90 days.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Jun 30, 2027-$0.35-$0.35-$0.35-$0.35-$0.35N/A
    Fiscal year ending Jun 30, 2028-$0.35-$0.35-$0.35-$0.35-$0.35N/A
    Quarter ending Dec 31, 2026-$0.08-$0.08-$0.08-$0.08-$0.08N/A

    Frequently Asked Questions About NNVC

    What is the NNVC stock forecast?

    Consensus analyst estimates put NanoViricides's EPS at -$0.35 for the fiscal year ending Jun 30, 2027.

    What EPS do analysts expect from NNVC next year?

    For the fiscal year ending Jun 30, 2027, the consensus EPS estimate is -$0.35, with estimates from -$0.35 to -$0.35 from 1 analyst. For the fiscal year ending Jun 30, 2028, the consensus EPS estimate is -$0.35, with estimates from -$0.35 to -$0.35 from 1 analyst.

    What revenue do analysts expect from NanoViricides next year?

    For the fiscal year ending Jun 30, 2028, the consensus revenue estimate is $76.50M, with estimates from $76.50M to $76.50M.

    How many analysts cover NNVC?

    1 analyst estimates EPS for NanoViricides for the fiscal year ending Jun 30, 2027.